Surgery Partners, Inc. Completes Refinancing Transaction
06 Décembre 2023 - 3:17PM
Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or
the “Company”), a leading short-stay surgical facility owner and
operator, announced today that Surgery Center Holdings, Inc., a
wholly owned subsidiary of the Company, has received commitments
for a new $1.4 billion senior secured term loan (the “New Term
Loan”). Upon closing (such date, the “Closing Date”), the new Term
Loan will bear interest at a rate equal to 3.50% per annum in
excess of the applicable Secured Overnight Financing Rate (SOFR)
index rate (or, at the option of the Company, 2.50% per annum in
excess of an adjusted base rate), will mature on the date that is
seven years after the Closing Date and will be subject to customary
terms and conditions. Additionally, the Company expects to
refinance and increase its existing revolving credit facility with
a new senior secured revolving credit facility in an aggregate
principal amount of approximately $703.75 million (together with
the New Term Loan, the “New Credit Facilities”) that matures five
years after the Closing Date, on customary terms and conditions.
The Company intends to use the net cash
proceeds from the New Term Loan to repay in full its existing
senior secured term loan due 2026, and to fund transaction fees and
expenses in connection with the foregoing. The closing of the New
Credit Facilities is subject to customary conditions and is
expected to occur in December 2023.
Dave Doherty, Chief Financial Officer of Surgery
Partners, noted “We are pleased with the support from investors in
our refinanced term loan and the banking syndicate that supports
our revolving credit facility. This new term loan provides more
favorable terms, extends the maturity date and has a more favorable
interest rate than our prior term loan, reducing interest
costs. Combined with an increased revolving credit
facility, our strong liquidity position positions us
well to continue to execute on our Adjusted EBITDA growth
goals.”
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery
Partners is a leading healthcare services company with a
differentiated outpatient delivery model focused on providing high
quality, cost effective solutions for surgical and related
ancillary care in support of both patients and physicians. Founded
in 2004, Surgery Partners is one of the largest and fastest growing
surgical services businesses in the country, with more than 180
locations in 31 states, including ambulatory surgery centers,
surgical hospitals, multi-specialty physician practices and urgent
care facilities. For additional information, visit
www.surgerypartners.com.
Forward-Looking Statements
This press release contains forward-looking
statements, including those regarding the term loan and
revolving credit agreement refinancing transactions, including the
anticipated timing, amount and use of proceeds of the refinancing
transactions. These statements can be identified by the use of
words such as “believes," “anticipates,” “expects,” “intends,”
“plans,” “continues,” “estimates,” “predicts,” “projects,”
“forecasts,” “may,” “could,” and similar expressions. All
forward-looking statements are based on current expectations and
beliefs as of the date of this release and are subject to risks,
uncertainties and other factors that may cause actual results to
differ materially from the expectations discussed in, or implied
by, the forward-looking statements. Many of these factors are
beyond our ability to control or predict including, without
limitation, reductions in payments from government health care
programs and private insurance payors, such as health maintenance
organizations, preferred provider organizations, and other managed
care organizations and employers; our ability to contract with
private insurance payors; changes in our payor mix or surgical case
mix; failure to maintain or develop relationships with physicians
on beneficial or favorable terms, or at all; the impact of payor
controls designed to reduce the number of surgical procedures; our
efforts to integrate operations of acquired businesses and surgical
facilities, attract new physician partners, or acquire additional
surgical facilities; supply chain issues, including shortages or
quality control issues with surgery-related products, equipment and
medical supplies; competition for physicians, nurses, strategic
relationships, acquisitions and managed care contracts; our ability
to attract and retain qualified health care professionals; our
ability to enforce non-compete restrictions against our physicians;
our ability to manage material liabilities whether known or unknown
incurred as a result of acquiring surgical facilities; the impact
of future legislation and other health care regulatory reform
actions, and the effect of that legislation and other regulatory
actions on our business; our ability to comply with current health
care laws and regulations; the outcome of legal and regulatory
proceedings that have been or may be brought against us; the impact
of cybersecurity attacks or intrusions, changes in the regulatory,
economic and other conditions of the states where our surgical
facilities are located; our indebtedness; the social and economic
impact of a pandemic, epidemic or outbreak of a contagious disease,
such as COVID-19, on our business; and the risks and uncertainties
identified and discussed from time to time in the Company’s reports
filed with the SEC, including in Item 1A under the heading “Risk
Factors” in the Company’s Annual Report on Form 10-K for the year
ended December 31, 2022. Except as required by law, the Company
undertakes no obligation to revise or update publicly any
forward-looking statements to reflect events or circumstances after
the date of this report, or to reflect the occurrence of
unanticipated events or circumstances.
Contact:
Surgery Partners Investor Relations (615)
234-8940IR@surgerypartners.com
Surgery Partners (NASDAQ:SGRY)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Surgery Partners (NASDAQ:SGRY)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025